Envision Pharma Group (Envision) has appointed Jay Ferro as President, Technology and Chief Product Officer (CPO). He joins Envision from Clario, a global clinical trial endpoint and technology ...
The EU HTA reforms give patients a formal role in assessing new medicines, but meaningful involvement requires more than ...
ELRIG, a not-for-profit, volunteer-led organisation dedicated to the global drug discovery community, has appointed Hitesh ...
A supplemental New Drug Application (sNDA) for Pfizer’s Talzenna (talazoparib) in combination with Xtandi (enzalutamide) has ...
Veradermics has announced positive topline results from its open-label phase 2 clinical trial (Study ‘207’) evaluating ...
Almirall’s submission to extend its Marketing Authorisation Application (MAA) for Ebglyss (lebrikizumab) to treat moderate-to ...
Takeda has announced new data from the two pivotal phase 3 studies of zasocitinib (TAK-279) in adults with moderate-to-severe ...
The unique combination of technology marks 25 years of industry innovation and expertise, and signals company’s next phase of ...
AstraZeneca has entered into an exclusive licence agreement with Dizal Pharmaceutical for Zegfrovy (sunvozertinib), a novel ...
How do we translate individual experiences into support that helps others and create support that feels personal but remains ...
Independent network The Bloc has appointed Jon Chapman as European Executive Creative Director. Chapman previously held ...
Bristol Myers Squibb’s New Drug Application (NDA) for mezigdomide has been accepted by the US FDA. Mezigdomide is an oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results